In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Medtechs Fear That Pre-COVID-19 Activity May Be Over A Year Away

Long Waiting Lists And Patients' Reluctance To Present For Cancer And Other Care Are Compounding An Already Difficult Situation

Executive Summary

Top of the agenda for the medtech industry globally is when the “new normal” will return. In the UK, the expectations are that post-COVID-19 health care activity will increase gradually, but it is possible that the National Health Service will not reach its pre-coronavirus capacities until late in 2021, “if at all.”

You may also be interested in...



Medtechs’ View Of UK Brexit Deal: More Certainty, But Still No Detail

COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.

French Market: Scale-Up Problems Are Preventing Start-Ups From Flourishing

Better medtech industry-government dialog is needed to improve the adoption of innovative medical devices by the French health care system. The current pathway is not obvious or easy, according to local manufacturers.

Improving Health Care Productivity Means ‘Locking Arms With Providers’

Royal Philips would not routinely invest 10% of its sales in R&D without working with providers to discover their precise needs, says CEO Frans van Houten.

Topics

UsernamePublicRestriction

Register

ID1122434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel